On 12/28/23, Marker Therapeutics Inc (NASDAQ: MRKR) stock enjoyed a major increase of 35.6%, closing at $5.75. Moreover, unusually high trading volume at 152% of normal accompanied the advance. The stock has been exceptionally strong relative to the market over the last nine months and has risen 35.3% during the last week.
Current PriceTarget Research Rating
MRKR’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to continue to be a modest Value Eraser.
Marker Therapeutics has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Marker Therapeutics has a very low Appreciation Score of 11 but a very high Power Rating of 94, triggering the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment